Many adults who consider themselves moderate drinkers may be unknowingly harming their livers by bingeing just once a month, according to new research from the University of Southern California’s Keck School of Medicine that challenges long-held assumptions about “safe” occasional heavy drinking.

The study, published April 2, 2026, in the journal Clinical Gastroenterology and Hepatology, found that people with metabolic dysfunction–associated steatotic liver disease (MASLD) who consume four or more drinks in a single day for women or five or more for men at least once a month face nearly three times the odds of developing advanced liver fibrosis compared with those who spread out the same total weekly alcohol intake more evenly.

MASLD, formerly known as nonalcoholic fatty liver disease, affects about one in three U.S. adults and is closely linked to obesity, type 2 diabetes and metabolic syndrome. The condition causes fat to build up in the liver, making the organ more vulnerable to inflammation and scarring when exposed to alcohol spikes.

Researchers analyzed data from more than 8,000 U.S. adults participating in the National Health and Nutrition Examination Survey (NHANES) between 2017 and 2023. Among nearly 4,000 participants with MASLD who had liver stiffness measurements via vibration-controlled transient elastography, 15.9% reported episodic heavy drinking — defined as the binge threshold at least once a month.

After adjusting for age, sex and average weekly alcohol consumption, those with episodic heavy drinking had 69% higher odds of significant liver fibrosis and nearly three times higher odds (adjusted odds ratio 2.76) of advanced fibrosis. The weighted prevalence of significant fibrosis was 23.6% among episodic heavy drinkers with MASLD versus 15.6% among those who did not binge.

Lead author Dr. Brian P. Lee, a hepatologist and liver transplant specialist at Keck Medicine of USC, said the findings deliver a clear message: “It’s not just how much you drink, but how you drink it.”

“When the liver is already fatty from metabolic issues, a sudden large influx of alcohol overwhelms its ability to process toxins, triggering intense inflammation that promotes scarring over time,” Lee explained in a university release. “Spreading the same number of drinks across the week appears far less damaging.”

The study compared individuals with identical average weekly intake but different patterns — one group with monthly binges, the other drinking more steadily. The difference in advanced fibrosis risk was striking even among people who stayed within generally accepted moderate limits of up to 14 drinks per week for men and seven for women.

More than half of all adults in the broader sample reported some form of episodic heavy drinking, underscoring how common the behavior is. For the roughly 100 million Americans with MASLD, the implications are significant, researchers said.

Liver fibrosis occurs when repeated injury causes scar tissue to replace healthy liver cells. In early stages it may produce no symptoms, but advanced fibrosis can progress to cirrhosis, liver failure or liver cancer. Once scarring reaches advanced levels, damage is often irreversible, though progression can sometimes be slowed with lifestyle changes.

Experts not involved in the study called the results concerning but consistent with emerging understanding of alcohol’s interaction with metabolic liver disease.

“This research highlights that binge patterns create acute stress the liver cannot fully recover from between episodes, especially when fat accumulation has already compromised function,” said Dr. Anna Mae Diehl, a hepatologist at Duke University who has studied MASLD for decades. “The old idea that moderate average intake is protective regardless of pattern needs updating.”

The findings add nuance to national drinking guidelines. While many health organizations define low-risk drinking by weekly totals, the USC study suggests daily peaks matter independently for people with underlying liver fat.

Public health implications could be broad. MASLD rates continue rising alongside obesity and diabetes epidemics. Many affected individuals remain undiagnosed because the disease is often silent until advanced stages. Routine screening for liver fat or fibrosis is not yet standard in primary care for all at-risk adults.

Researchers noted limitations in the observational data. Self-reported drinking can understate actual consumption, and the study could not prove causation, though the pattern held after statistical adjustments. Longitudinal studies tracking drinking habits and liver outcomes over years would strengthen the evidence.

Still, the authors argue the results should prompt clinicians to ask patients not only how much they drink weekly but whether they have heavy drinking days.

“Patients with MASLD should be counseled to avoid binge episodes entirely, even if their average intake seems moderate,” Lee recommended. “Complete abstinence from alcohol remains the safest option for those with known liver disease, but for others, spreading intake and staying well below binge thresholds appears wiser.”

The study also examined how reclassifying episodic heavy drinkers might shift diagnoses between MASLD, metabolic and alcohol-associated liver disease (MetALD), and pure alcohol-associated liver disease. Including binge patterns increased the proportion identified as having alcohol-related contributions.

As awareness grows, experts hope the research will encourage more honest conversations about drinking patterns during medical visits. Simple blood tests and noninvasive liver scans can now detect fibrosis earlier, offering opportunities for intervention before irreversible damage occurs.

For the general public, the takeaway is cautionary: an occasional “big night” that feels harmless may carry hidden costs, particularly for the millions already living with fatty liver.

Lifestyle measures that help overall metabolic health — weight management, regular exercise, blood sugar control and a balanced diet — also support liver resilience. Reducing or eliminating alcohol provides additional protection.

The USC team plans further research into mechanisms, genetic factors and whether certain populations face even higher vulnerability. In the meantime, the April 2026 publication serves as a timely reminder that when it comes to alcohol and liver health, the pattern of consumption may matter as much as the total volume.

Health organizations are reviewing the data for potential updates to patient education materials. In the interim, physicians say the study reinforces a simple principle: protecting the liver means thinking beyond weekly averages to daily realities.